Robert C. Schuit
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
Exploration of Fluorinated Pyrazolidine-3,5-Diones for Positron Emission Tomography Imaging of the P2Y12 Receptor in the Central Nervous System.
Journal: ChemMedChem
Published: June 11, 2025
Imaging Proinflammatory Microglia in Parkinson Disease Using [11C]SMW139 PET: A Multicenter Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 05, 2025
Varying Levels of Inflammatory Activity in Brain and Body of Patients with Persistent Fatigue and Difficulty Concentrating After COVID-19: A TSPO PET Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 07, 2025
Assessment of fully quantitative and simplified methods for analysis of [68Ga]Ga-FAPI-46 uptake in patients with pancreatobiliary cancer using LAFOV PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 10, 2024
Development and evaluation of [11C]DPA-813 and [18F]DPA-814: novel TSPO PET tracers insensitive to human single nucleotide polymorphism rs6971.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 10, 2024
Pharmacokinetic analysis and simplified uptake measures for tumour lesion [18F]F-AraG PET imaging in patients with non-small cell lung cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 28, 2024
Development of 18F-Labeled PET Tracer Candidates for Imaging of the Abelson Non-receptor Tyrosine Kinase in Parkinson's Disease.
Journal: Journal of medicinal chemistry
Published: September 15, 2023
Synthesis and Preclinical Evaluation of [Methylpiperazine-11C]brigatinib as a PET Tracer Targeting Both Mutated Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase.
Journal: Journal of medicinal chemistry
Published: August 30, 2023
Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor.
Journal: EJNMMI research
Published: August 08, 2023
Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor.
Journal: Nuclear medicine and biology
Published: February 22, 2023
Last Updated: 09/26/2026